Diclofenac transdermal - Elan Pharma/Laboratorios Beta

Drug Profile

Diclofenac transdermal - Elan Pharma/Laboratorios Beta

Alternative Names: Oxa Sat

Latest Information Update: 01 Feb 2000

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Elan Pharma International
  • Class Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
  • Mechanism of Action Arachidonic acid inhibitors; Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Inflammation; Musculoskeletal disorders

Most Recent Events

  • 01 Feb 2000 Ethical Holdings is now called Amarin Corporation
  • 09 Jun 1999 New profile
  • 09 Jun 1999 Launched for Inflammation in Argentina (Transdermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top